These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3141208)

  • 21. Dyserythropoiesis and erythroblast-phagocytosis preceding pure red cell aplasia.
    Keefer MJ; Solanki DL
    Am J Hematol; 1988 Feb; 27(2):132-5. PubMed ID: 3124607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man.
    Lipton JM; Nadler LM; Canellos GP; Kudisch M; Reiss CS; Nathan DG
    J Clin Invest; 1983 Aug; 72(2):694-706. PubMed ID: 6223945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is pure red cell aplasia (PRCA) a clonal disorder?
    Sivakumaran M; Bhavnani M; Stewart A; Roberts BE; Geary GC
    Clin Lab Haematol; 1993; 15(1):1-5. PubMed ID: 8386075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocytes and antibody in retrovirus-induced feline pure red cell aplasia.
    Abkowitz JL; Ott RL; Holly RD; Adamson JW
    J Natl Cancer Inst; 1987 Jan; 78(1):135-9. PubMed ID: 3025500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of natural killer cells in a child with pure red blood cell aplasia.
    Abrahamov A; Schlesinger M
    Am J Hematol; 1990 Dec; 35(4):258-62. PubMed ID: 2122723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.
    Mangan KF; Chikkappa G; Farley PC
    J Clin Invest; 1982 Dec; 70(6):1148-56. PubMed ID: 6816810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of refractory pure red cell aplasia secondary to chronic lymphocytic leukaemia with cyclosporine A: correlation between clinical and in vitro effects.
    Gotic M; Basara N; Rolovic Z; Boskovic D; Antunovic P; Marisavljevic D; Brkic S
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):307-9. PubMed ID: 7971250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period.
    Laso FJ; Madruga JI; López A; Ciudad J; Alvarez-Mon M; San Miguel J; Orfao A
    Alcohol Clin Exp Res; 1997 Jun; 21(4):672-6. PubMed ID: 9194923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.
    Binder D; Fehr J; Hengartner H; Zinkernagel RM
    J Exp Med; 1997 Feb; 185(3):517-30. PubMed ID: 9053452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporin A for the treatment of pure red cell aplasia associated with myelodysplasia.
    Grigg AP; O'Flaherty E
    Leuk Lymphoma; 2001; 42(6):1339-42. PubMed ID: 11911417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
    Thiele DL; Lipsky PE
    J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilineage hematopoietic inhibitor and T lymphocyte dysfunction in a patient with pure red cell aplasia, myasthenia gravis and thymoma.
    Murase T
    Exp Hematol; 1993 Mar; 21(3):451-5. PubMed ID: 8440342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal T cell proliferation in patients with pure red cell aplasia.
    Yamada O
    Leuk Lymphoma; 1999 Sep; 35(1-2):69-82. PubMed ID: 10512164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The interrelation of the expression of HLA class I and II proteins and of the costimulatory proteins CD11a/CD18 and CD16 with the lytic activity of resting and activated natural killer lymphocytes].
    Musatov MI; Petrova ED; Konenkov VI
    Tsitologiia; 1997; 39(7):617-28. PubMed ID: 9490502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of human T-helper/inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK)-cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin.
    Ramachandran C; Wilk BJ; Hotchkiss A; Chau H; Eliaz I; Melnick SJ
    BMC Complement Altern Med; 2011 Aug; 11():59. PubMed ID: 21816083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pure red-cell aplasia in patients with chronic lymphocytic leukemia.
    Chikkappa G; Zarrabi MH; Tsan MF
    Medicine (Baltimore); 1986 Sep; 65(5):339-51. PubMed ID: 3091991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDR3-independent expansion of Vδ1 T lymphocytes in acquired chronic pure red cell aplasia.
    Michishita Y; Hirokawa M; Fujishima N; Abe Y; Fujishima M; Guo YM; Ubukawa K; Liu J; Yoshioka T; Kameoka Y; Saitoh H; Tagawa H; Takahashi N; Sawada K
    Immunol Lett; 2013 Feb; 150(1-2):23-9. PubMed ID: 23274961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A sustained response to low dose interferon-alpha in a case of refractory pure red cell aplasia.
    Nadeau L; Meyerson H; Warren G; Koç ON
    Eur J Haematol; 2004 Oct; 73(4):300-3. PubMed ID: 15347318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.